Editorial

Carbapenem-Hydrolyzing Enzyme-Producing Enterobacteria: A Great Challenge

Authors: Mercedes Treviño, PhD

Abstract

The increase in antibiotic resistance among Gram-negative bacteria is a notable example of how bacteria can procure, maintain, and express new genetic information that can confer resistance to one or several antibiotics. This genetic plasticity can occur both inter- and intragenerically. Reports of resistance vary, but a general consensus appears to prevail that quinolone and broad-spectrum β-lactam resistance is increasing in members of the family Enterobacteriaceae.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Castanheira M, Sader HS, Deshpande LM, et al. Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report form the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2008;52:570–573.
 
2. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002;8:321–331.
 
3. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151–1161.
 
4. Lo A, Verrall R, Williams S, et al. Carbapenem resistance via the blaKPC-2 Gene in Enterobacter cloacae blood culture isolate. South Med J 2010;103:453–454.
 
5. Queenam AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007;51:2611–2614.
 
6. CDC, Healthcare Infection Control Practices Advisory Committee. Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006. Atlanta, GA, US Department of Health and Human Services, CDC, Healthcare Infection Control Practices Advisory Committee, 2007.